InnoCare Optoelectronics (6861) Q3 2024 earnings summary

Executive summary

• Revenue for Q3 2023 was NT$483.7 million, up 19% year-over-year; net income for the quarter was NT$30.9 million, with basic EPS of NT$0.75.

• For the nine months ended September 30, 2023, revenue reached NT$1,452 million, up 9% year-over-year; net income was NT$112.3 million, with basic EPS of NT$2.77.

• The company’s financial statements for Q3 2023 were reviewed by Deloitte and found to be in compliance with IFRS and local regulations, with no material misstatements identified.

Financial highlights

• Gross margin for Q3 2023 was 29%, slightly down from 31% in Q3 2022.

• Operating income for Q3 2023 was NT$8.9 million, up from NT$8.6 million in Q3 2022.

• Operating expenses increased, mainly due to higher R&D spending (NT$71.5 million in Q3 2023 vs. NT$59.2 million in Q3 2022).

• Cash and cash equivalents at September 30, 2023, were NT$690.4 million, down from NT$941.0 million a year earlier.

• Short-term borrowings decreased to NT$100 million from NT$350 million at the end of Q3 2022.

Outlook and guidance

• The company continues to invest in R&D and expects ongoing support from government grants.

• No significant changes in accounting policies or standards are expected to materially impact future results.